QESDION Trademark

Trademark Overview


On Friday, June 20, 2008, a trademark application was filed for QESDION with the United States Patent and Trademark Office. The USPTO has given the QESDION trademark a serial number of 77503899. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, March 13, 2009. This trademark is owned by Pfizer Inc.. The QESDION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, pharmaceutical preparation for the treatment of sleep disorders
qesdion

General Information


Serial Number77503899
Word MarkQESDION
Filing DateFriday, June 20, 2008
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, March 13, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 11, 2008

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, pharmaceutical preparation for the treatment of sleep disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, March 13, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, March 13, 2009ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Friday, March 13, 2009ABANDONMENT - AFTER PUBLICATION
Thursday, March 12, 2009TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, February 3, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 11, 2008PUBLISHED FOR OPPOSITION
Wednesday, October 22, 2008NOTICE OF PUBLICATION
Wednesday, October 8, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 8, 2008ASSIGNED TO LIE
Friday, September 26, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 19, 2008ASSIGNED TO EXAMINER
Tuesday, June 24, 2008NEW APPLICATION ENTERED IN TRAM